Obesity has become a major global problem. Since 1975, the number of overweight people around the world has almost tripled, ...

The study — published recently in the journal Social Science & Medicine — identified three key high school factors linked to ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

New York lawmakers are pushing to strengthen laws banning false, predatory marketing and advertising for unhealthy foods to curb childhood obesity.

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

In just two months as the federal health secretary, Robert F. Kennedy Jr. has made sweeping changes to the Department of ...

Augusta University professor's research will focus on providing free or low-cost after-school care for children with cardiovascular risk factors.

Increased awareness and knowledge of GLP-1/GIP receptor agonists among women, with insights into public perspectives on ...

It’s all about GLP-1s on this week’s episode. For the Trends segment, we’re continuing the GLP-1 focus with an update on how Eli Lilly is overtaking Novo Nordisk in the diabetes and obesity treatment ...